Flexcell
Flexcell International Corporation is a Burlington, North Carolina–based manufacturer of bioreactor and mechanical stimulation devices for 2D and 3D cell culture, serving academic and research laboratories worldwide with capital equipment, consumables, and control software.
- Company typePrivate
- Founded1987
- HeadquartersHillsborough, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Flexcell does
Flexcell International Corporation is a privately held specialty life-science instrument manufacturer founded in 1987 and headquartered in Burlington, North Carolina. The company designs and builds devices — including the FX-3000, FX-5000, and Flex Jr. systems — that apply controlled tension, compression, and fluid shear to cells cultured in 2D and 3D environments, enabling researchers to model mechanical loading conditions found in vivo. Its technology is grounded in a deep foundational patent portfolio originated by founder Albert Banes and co-inventors, and its trademarks are co-held with Medtrain Technologies, LLC.
Flexcell's primary customer base is academic and research institutions worldwide, evidenced by more than 7,000 peer-reviewed publications that cite its products and named users including the University of Nebraska-Lincoln, Shanghai Jiao Tong University, the University of Notre Dame, the Chinese University of Hong Kong, and Alamance Community College. The company sells direct in the US, Canada, Australia, South America, and Israel, and reaches other geographies through a network of international distributors.
The business model combines capital-equipment sales with a multi-pronged recurring stream: consumables and disposables, replacement accessories and spare parts, equipment leasing (6- and 12-month terms in Canada/US), and FlexSoft software licensing. A 6-week free trial program in Canada and the US is designed to lower adoption friction. The most recent product extension is the Platron automation system, launched in 2024, and the firm is led by founder and CEO Albert Banes with COO Andrea Picon (appointed November 2021).
Flexcell firmographics
Firmographics- Name
- Flexcell
- Legal name
- Flexcell® International Corporation
- Website
- https://flexcellint.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Flexcell International Corporation is a Burlington, North Carolina–based manufacturer of bioreactor and mechanical stimulation devices for 2D and 3D cell culture, serving academic and research laboratories worldwide with capital equipment, consumables, and control software.
- Ownership category
- akta.pro rank
Flexcell industry classification
Industry- Product category
- Mechanobiology & Cell Culture Bioreactor Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Plastics Packaging Film and Sheet (including Laminated) Manufacturing (326112)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)
Keywords
Where Flexcell is headquartered
LocationHeadquarters
- HQ city
- Hillsborough
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Flexcell business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Equipment (capital) sales: One-time sale of capital bioreactor systems: FX-6000™ Tension System, FX-5000™ Compression, FX-5000™ Tension, Flex Jr.™, Tissue Train® 3D Culture System, StageFlexer®, StagePresser™, Streamer® STR-4000, FlexFlow™, Osci-Flow® controllers.
- Consumable / disposable sales: Recurring revenue from single-use flexible-bottom culture plates (BioFlex®, HT BioFlex®, UniFlex®, Tissue Train® Linear/Cerex/Foam/Circular, BioPress™, CellSoft®, Culture Slips®), Loading Stations™, Cell Seeders™, Arctangle® posts, Trough Loaders™, ScanFlex™ consumables and Collagel®/Thermacol® hydrogel kits — sold by the case or by the each.
- Accessories and spare parts: One-time sale of strain accessories, microscopy devices, baseplate kits, water traps, drying filters, vacuum pumps and pressure reservoirs that complement the bioreactor systems.
- Equipment leasing: 6-month and 12-month renewable leases offered in Canada and the United States as an alternative to outright equipment purchase.
- Software licensing (FlexSoft® / StreamSoft): Proprietary control software is bundled with each system and updated via calibration files and patches distributed to existing customers (e.g., FlexSoft® FX-6000™ software, StreamSoft v. 4.1).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Quote-based capital equipment purchase |
| Unit Pricing | Pay-as-you-go | Consumables and disposables — unit pricing |
| Subscription | Monthly | Equipment leasing (Canada/US only) |
| Other | — | Complimentary 6-week equipment trial |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels9 records
Flexcell product offering
Product offeringCore offering
Flexcell® International Corporation designs, develops and manufactures dynamic cell stretching bioreactor systems and matched disposables that apply controlled tension, compression, and fluid shear to cells in 2D monolayer and 3D hydrogel cultures. Its product platform is anchored by the FX-6000™ and FX-5000™ Tension Systems, the Tissue Train® 3D Culture System, the BioPress™ Compression System, and the Streamer® Fluid Shear System, paired with proprietary FlexSoft® and StreamSoft v. 4.1 control software and a family of patented flexible-bottom culture plates, loading stations, baseplate kits, and microscopy devices. The company also supplies single-use consumables (BioFlex®, HT BioFlex®, UniFlex®, Tissue Train® Linear/Circular, CellSoft® and Culture Slips® plates, Collagel®/Thermacol® hydrogel kits) and accessories on a per-unit or per-case basis to life science research laboratories.
Product overview
Flexcell® offers a single, integrated platform of dynamic cell stretching bioreactor systems and matched disposables organized around three mechanical load types: Tension (FX-6000™ Tension System, FX-5000™ Tension System, Flexcell® Flex Jr.™ Tension System, and the Tissue Train® 3D Culture System), Compression (BioPress™ Compression System), and Fluid Shear (Streamer® Fluid Shear System, Osci-Flow®, FlexFlow™). The architecture pairs each computer-regulated hardware system with proprietary control software (FlexSoft®) and a family of optional controllers (FX-6000™ FlexLink® Controller) and strain accessories (BioFlex® Loading Station™, Arctangle® Loading Station™, BioFlex® and UniFlex® Baseplate Kits, Cell Seeder™ 6-Well, Trough Loaders™, FlexStop™), plus microscopy-compatible add-ons (StageFlexer®, StageFlexer® Jr, Inverted StageFlexer®, StagePresser™) and an imaging pair (ScanFlex™ with XyFlex™ software). A separate consumables portfolio — flexible-bottom culture plates (BioFlex®, HT BioFlex®, UniFlex®, CellSoft®, Culture Slips®), 3D Tissue Train® Linear and Circular culture plates, and collagen hydrogel kits (Collagel®, Thermacol®) — plugs into the systems to deliver equibiaxial, uniaxial, and compressive mechanical loading to 2D monolayers and 3D bioartificial tissue constructs.
Differentiator
Problem solved
Functional benefit
Brands
- BioFlex®: Flexible-bottom culture plates used to apply equibiaxial load with Flexcell Tension Systems.
- Tissue Train®
- Osci-Flow®
- Streamer®
- Culture Slips®
- Arctangle®
- Collagel®
- FlexLink®
- StageFlexer®
- UniFlex®
- Thermacol® / ThermaCol®
- HiQ Flowmate®
- CellSoft®
- FX-5000T™
- FX-6000T™
- Flex Jr.™
- StagePresser™
- BioPress™
- Cell Seeder™
- Trough Loader™
- FlexStop™
- FlexFlow™
- Loading Station™
- ScanFlex™
Products and services
- FX-6000™ Tension System Computer-regulated dynamic bioreactor that uses vacuum and positive air pressure to apply cyclic or static mechanical strain (equibiaxial or uniaxial) to cells on flexible-bottomed culture plates, supporting static, sinusoidal, heart-stimulation, triangular, square and custom waveforms programmed via FlexSoft® software. Supports up to four additional Tension FlexLink® controllers per system for parallel regimens. Used by academic and commercial mechanobiology and tissue engineering research laboratories.
- FX-5000™ Tension System Computer-regulated pneumatic tension bioreactor system applying cyclic or static equibiaxial and uniaxial strain to cells in 2D monolayer and 3D culture, controlled via FlexSoft® software and Tension FlexLink® controllers. Used by life science research laboratories for mechanobiology and tissue engineering.
- Flex Jr.™ Tension System Compact version of the Flexcell® Tension System for applying tensile strain to cultured cells on flexible-bottom plates, supplied with its own user manual and specification sheet. Targeted at individual labs and teaching/training environments that need a smaller-footprint system.
- Tissue Train® 3D Culture System Computer-regulated bioreactor for creating 3D cell-seeded hydrogel constructs in linear, circular, or custom shapes up to 35 mm in length, applying uniaxial or equibiaxial cyclic strain regimens simulating heart rate, walking, running and other exercise patterns. Used by academic and commercial tissue engineering, tendon, cartilage, and musculoskeletal research laboratories.
- BioPress™ Compression System Flexcell® Compression System that regulates positive air pressure to compress tissue samples or 3D cell cultures in vitro, including a Compression Plus configuration used for longer-term compression of multicellular aggregates in hydrogel carriers. Used in EMT, multicellular aggregate, and tissue engineering research.
- Streamer® Fluid Shear System Fluid shear stress device (STR-4000) allowing users to apply laminar, pulsatile, or oscillating fluid flow to cells in culture. Operates with a computer-controlled peristaltic pump and StreamSoft v. 4.1 software for flow regimen control. Used in flowtaxis, mechanosensor (e.g., ROCK), and endothelial cell research.
- FlexSoft® Control Software Proprietary laptop-based software (FlexSoft®) shipped with Tension Systems via a FlexCentral® laptop, used to program strain regimens including frequency, amplitude, and waveform changes. Bundled with each FX-5000™ / FX-6000™ Tension System and updated via calibration files and patches distributed to existing customers.
- StageFlexer® / StageFlexer® Jr / Inverted StageFlexer® / StagePresser™ Microscopy stretching and compression stages for live-cell imaging under mechanical load. StageFlexer® and StageFlexer® Jr apply tensile strain during imaging; Inverted StageFlexer® fits inverted microscopes (Tech Report 116); StagePresser™ applies compressive load to cells during live-cell imaging. Each ships with its own user manual and dedicated disposable membranes.
- ScanFlex™ Automated Scanning Device with XyFlex® Area Measurement Software Automated scanning device used with XyFlex® area measurement software for measuring gel compaction in three-dimensional bioartificial tissues. Documented in Tech Report 107 and sold to tissue engineering and 3D construct laboratories.
- Osci-Flow® Flow Controller Oscillating flow controller used with the Streamer® system and a MasterFlex peristaltic pump to deliver pulsatile or oscillating fluid shear stress regimens to cells in culture. Sold as a standalone add-on to the Streamer® platform.
- FlexFlow™ Flow-and-Stretch Module Device that can be assembled in flow-only mode or in flow-and-stretch mode by connecting in line with the FX-6000™ Tension System, enabling simultaneous fluid flow and tensile strain on cultures. Sold as a standalone add-on for combined mechanobiology workflows.
- BioFlex® 6-Well Culture Plates Patented flexible-bottom 6-well culture plate used with Flexcell® Tension Systems to apply equibiaxial load to 2D monolayer cultures, available in untreated or covalently bonded matrix coatings (Amino, Collagen Type I, Collagen Type IV, Laminin/YIGSR). Sold by the each or by case (typically Case of 40).
- HT BioFlex® Culture Plates 24-well high-throughput flexible-bottom culture plates for equibiaxial strain on silicone membranes, designed for higher-throughput screening workflows and documented in Tech Report 108. Sold as single-use disposable cultureware.
- UniFlex® Culture Plates Flexible-bottom culture plates used with Arctangle® Loading Stations™ to apply uniaxial tensile strain, available with covalently bonded matrix coatings (Amino, Collagen Type I, Collagen Type IV, Laminin/YIGSR, Untreated). Sold by the each or by case.
- Tissue Train® Linear and Circular Culture Plates (Cerex, Foam) 3D culture plates used with a Linear or Circular Trough Loader™ to create tethered, linear or spheroid cell-seeded hydrogel constructs. Linear (Cerex nylon mesh or urethane polyester foam anchor tabs) variants are used for tendon, cartilage, intestinal organoid, and musculoskeletal research; Circular Foam variants are used for dermis, lung and ocular research, drug testing, and tissue engineering. Available with multiple matrix coatings.
- CellSoft® Soft Substrate Cultureware Soft substrate cultureware (100 mm round dishes, 6-well BioFlex®, and 6-well Polystyrene variants) for sensitive cell lines, prolonging phenotype senescence and supporting regenerative medicine and bioprocessing applications. Sold as disposable cultureware.
- Collagel® and Thermacol® Hydrogel Kits Collagel® Collagen I hydrogel kit and Thermacol® thermoreversible Collagen I hydrogel kit for 3D cell culture, paired with Tissue Train® plates to fabricate 3D bioartificial tissue constructs. Documented in Tech Report 114. Sold as consumable reagent kits.
Quantifiable outcome
- More than 7,000 peer-reviewed science publications worldwide using Flexcell® products (as of 2024)
- +3 more outcomes
Companies that use Flexcell
Customer profileNamed customers5 records
Ideal customer profiles3 records
Flexcell technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature8 records
Flexcell partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- Alamance County Community College (ACC) — Biotechnology DepartmentminorFlexcell® donated tissue engineering equipment to the Biotechnology Department at Alamance Community College to provide students with the latest training in biomanufacturing technologies. The ACC Biotechnology Department has historically partnered with industry to push hands-on career-training programs for students. This is a community/educational partnership rather than a commercial channel.
- Medtrain Technologies, LLCcoreMedtrain Technologies, LLC is co-listed with Flexcell® International Corp. on the Patents & Trademarks page as a co-owner of certain registered trademarks in the Flexcell® product family. This indicates a longstanding IP-co-ownership relationship around the original Banes-AJ inventions and the Flexcell® brand family.
- International regional distributors (undisclosed names)coreFlexcell® products are sold worldwide through international regional distributors for any country outside Flexcell® International's direct markets (Australia, Canada, United States, South America, Israel). Distributors are not named publicly; customers must contact [email protected] or submit an online request to be connected to the local distributor in their region.
Scale indicators7 records
Recent moves5 records
Expansion highlights4 records
Flexcell competitors and assessment
Company assessmentEmerging players
- Organovo: Organovo is a 3D bioprinting and tissue-engineering company targeting drug discovery and disease modeling with engineered tissue constructs — adjacent to Flexcell's Tissue Train® 3D culture platform and competing for similar translational-research funding.
- Mimetas: Mimetas develops OrganoPlate microfluidic 3D cell culture platforms with perfusion and mechanical cues, overlapping with Flexcell's tissue engineering and shear-stress applications in preclinical drug-discovery workflows.
- Emulate: Emulate's organ-on-chip platforms incorporate fluid shear and mechanical stimulation to mimic human physiology; it competes for the same drug-discovery and disease-modeling budget that Flexcell addresses with its in vitro mechanical stimulation systems.
- CN Bio Innovations: CN Bio's Organ-on-Chip and PhysioMimix systems provide fluid flow and mechanical stimulation for in vitro modeling; comparable to Flexcell's tension and shear bioreactors as an alternative platform for disease modeling and drug discovery.
Broad incumbents
- Thermo Fisher Scientific (Life Sciences): Thermo Fisher's Life Sciences Solutions division supplies cell-culture instruments, bioreactors and consumables to the same academic and translational-research customers as Flexcell, and could expand into mechanobiology-adjacent bioreactor capabilities.
- Sartorius: Sartorius provides bioprocessing and cell-culture equipment (including bioreactor platforms) used in cell and gene therapy manufacturing and research; it is a broad incumbent that competes for the same lab budget as Flexcell in cell-based research workflows.
- Corning Life Sciences: Corning is a major incumbent in cell-culture plastics and bioprocessing consumables; through its broader portfolio it competes with Flexcell's disposable cultureware stream (BioFlex®, UniFlex®, HT BioFlex®) at the consumables layer even though it does not offer mechanical-stimulation bioreactors.
- Eppendorf: Eppendorf supplies cell-handling and bioprocessing consumables and instruments to academic and biotech labs, overlapping with Flexcell's life-science research customer base even though Eppendorf does not currently offer dedicated mechanical-stimulation bioreactors.
Direct peers
- CellScale: CellScale makes biomaterial and tissue mechanical-testing platforms (e.g., UniVert, MechanoCulture) used to apply controlled mechanical loads to cells and 3D constructs — directly comparable to Flexcell's tension/compression bioreactor offerings in mechanobiology and tissue engineering.
- Strex: Japan-based manufacturer of cell-stretching devices (Stretcher) that apply uniaxial mechanical strain to cultured cells — the closest direct competitor to Flexcell's tension bioreactor portfolio in the mechanobiology research market.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Flexcell social profiles
Digital presenceFlexcell financial estimates
Financial estimateRevenue estimate
Valuation estimate
Flexcell leadership team
Management profileNumber of profiles
Profiles2 records
Flexcell subsidiaries and ownership
Company hierarchySubsidiaries1 record
Flexcell funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Flexcell M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Flexcell
What does Flexcell do?
Flexcell® International Corporation designs, develops and manufactures dynamic cell stretching bioreactor systems and matched disposables that apply controlled tension, compression, and fluid shear to cells in 2D monolayer and 3D hydrogel cultures. Its product platform is anchored by the FX-6000™ and FX-5000™ Tension Systems, the Tissue Train® 3D Culture System, the BioPress™ Compression System, and the Streamer® Fluid Shear System, paired with proprietary FlexSoft® and StreamSoft v. 4.1 control software and a family of patented flexible-bottom culture plates, loading stations, baseplate kits, and microscopy devices. The company also supplies single-use consumables (BioFlex®, HT BioFlex®, UniFlex®, Tissue Train® Linear/Circular, CellSoft® and Culture Slips® plates, Collagel®/Thermacol® hydrogel kits) and accessories on a per-unit or per-case basis to life science research laboratories.
Is Flexcell a public or private company?
Flexcell is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Flexcell founded?
Flexcell was founded in 1987. It employs 11 to 50 people.
Where is Flexcell based?
Flexcell is headquartered in Hillsborough, United States, in the North America region.
How does Flexcell make money?
Five revenue lines are on record. Equipment (capital) sales are the primary driver. The others are consumable / disposable sales, accessories and spare parts, equipment leasing and software licensing (FlexSoft® / StreamSoft).
Who are Flexcell's main competitors?
Emerging players on record are Organovo, Mimetas, Emulate and CN Bio Innovations. Broad incumbents are Thermo Fisher Scientific (Life Sciences), Sartorius, Corning Life Sciences and Eppendorf. Direct peers are CellScale and Strex.
Does Flexcell have an API?
No public API is recorded for Flexcell.
What industry is Flexcell in?
Flexcell's product category is Mechanobiology & Cell Culture Bioreactor Equipment. Its primary akta.pro industry code is HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials). Its NAICS code is 334510 and its SIC code is 3842.